p.yildiz
Submits third-party assay reports on material purchased directly. Based in Kraków.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
99.31%
n=9
Suppliers covered
7
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042666 | CJC-1295 (no DAC) | GGPeps | GGPE-2606-E8495 | Janoshik | 2026-Q3 | 97.87 | 3.74 | 94.3 | Buyer-sourced | 2 | FAIL |
| AX-2026-041771 | Semaglutide | FGP | FGP-2602-M1508 | Janoshik | 2026-Q3 | 99.41 | 2.31 | — | Supplier-supplied | 0 | PASS |
| AX-2025-019102 | BPC-157 | JEEP | JEEP-2505-J3812 | Janoshik | 2025-Q4 | 99.59 | 3.10 | 99.2 | Supplier-supplied | 0 | PASS |
| AX-2025-019077 | Tirzepatide | JEEP | JEEP-2412-U3223 | Janoshik | 2025-Q2 | 98.71 | 2.52 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021188 | PT-141 (Bremelanotide) | BCH | BCH-2502-H6657 | Medutest | 2025-Q2 | 99.31 | 6.00 | 90.4 | Supplier-supplied | 0 | PASS |
| AX-2025-020197 | L-Glutathione (reduced) | GGPeps | GGPE-2501-J1308 | Janoshik | 2025-Q1 | 99.07 | 8.64 | 100.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019791 | GHRP-2 | HJ | HJ-2412-G3929 | Medutest | 2025-Q1 | 99.70 | 5.06 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004923 | Gonadorelin | ERP | ERP-2406-C7750 | Kestrel | 2024-Q3 | 99.52 | 3.70 | 97.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004374 | Retatrutide | QSC | QSC-2404-P8297 | Nordanalyt | 2024-Q2 | 98.27 | 6.24 | 91.5 | Laboratory-retained | 3 | MARGINAL |